首页> 美国政府科技报告 >Novel Inhibitors of FGF Signal transduction in Breast Cancer: Targeting the FGFR Adapter Protein SNT-1
【24h】

Novel Inhibitors of FGF Signal transduction in Breast Cancer: Targeting the FGFR Adapter Protein SNT-1

机译:新的FGF信号转导抑制剂在乳腺癌中:靶向FGFR衔接蛋白sNT-1

获取原文

摘要

FGF stimulation leads to tyrosine phosphorylation of the protein SNT- 1, which binds to activated FGF receptors. The objective of this work was to determine if SNT-1 protein had a central role in transducing the signals that lead to FGF-mediated antiestrogen resistant growth. We expressed an SNT-1 PTB domain in MCF-7 cells using a modified tetracycline inducible expression system. Upon induction of the PTB domain, we observed a significant decrease of FGF- dependent tyrosine phosphorylation of wild type SNT-1, strong inhibition of complex formation between SNT-1, Gab-1 and Sos-1, blocked activation of Ras as well as phosphorylation of MAP kinase indicating that the SNT-1 PTB domain was functioning in a dominant negative manner. Under the same conditions we did not observe a decrease in phosphorylation of AKT and Thr 389 of p70S6K, components of PI-3 kinase pathway. FGF dependent colony formation of MCF-7 cells in media containing the antiestrogen ICI 182,780 was inhibited upon induction of SNT-1 PTB domain. We conclude that SNT-1 plays a major role in the FGF-dependent activation of Ras/MAPK pathway and proliferation of MCF-7 cells and that overexpression of SNT-1 PTB domain can block these responses. We also suggest some SNT-1 independent mechanisms of PI- 3K activation by FGF.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号